Valentina Zanfagnin, MD
Valentina Zanfagnin, MD
Verified email at
Cited by
Cited by
Lower body lymphedema in patients with gynecologic cancer
N Biglia, V Zanfagnin, A Daniele, E Robba, VE Bounous
Anticancer Research 37 (8), 4005-4015, 2017
Risk factors, clinical presentation, and outcomes for abdominal wall endometriosis
Z Khan, V Zanfagnin, SA El-Nashar, AO Famuyide, GS Daftary, ...
Journal of minimally invasive gynecology 24 (3), 478-484, 2017
Prospective Validation of an Ex Vivo, Patient-Derived 3D Spheroid Model for Response Predictions in Newly Diagnosed Ovarian Cancer
S Shuford, C Wilhelm, M Rayner, A Elrod, M Millard, C Mattingly, ...
Scientific reports 9 (1), 11153, 2019
Current challenges in HER2-positive breast cancer
F Puglisi, C Fontanella, V Amoroso, GV Bianchi, G Bisagni, C Falci, ...
Critical Reviews in Oncology/Hematology 98, 211-221, 2016
Prevention of human lymphoproliferative tumor formation in ovarian cancer patient-derived xenografts
KA Butler, X Hou, MA Becker, V Zanfagnin, S Enderica-Gonzalez, ...
Neoplasia 19 (8), 628-636, 2017
Phase II trial of ribociclib and letrozole in patients with relapsed oestrogen receptor-positive ovarian or endometrial cancers
G Colon-Otero, V Zanfagnin, X Hou, NR Foster, EJ Asmus, ...
ESMO open 5 (5), e000926, 2020
Ovarian cancer in elderly patients: patterns of care and treatment outcomes according to age and modified frailty index
A Ferrero, L Fuso, E Tripodi, R Tana, A Daniele, V Zanfagnin, S Perotto, ...
International Journal of Gynecologic Cancer 27 (9), 2017
Epigenetic modulation of collagen 1A1: therapeutic implications in fibrosis and endometriosis
Y Zheng, Z Khan, V Zanfagnin, LF Correa, AA Delaney, GS Daftary
Biology of reproduction 94 (4), 87, 1-10, 2016
Gene expression differences between matched pairs of ovarian cancer patient tumors and patient-derived xenografts
Y Liu, P Chanana, JI Davila, X Hou, V Zanfagnin, CD McGehee, ...
Scientific reports 9 (1), 6314, 2019
Treatment of early cervical cancer: survival, complications and economical aspects
P Zola, E Tripodi, V Zanfagnin, S Perotto, P Modaffari, F Martra, L Fuso
Сибирский онкологический журнал, 5-13, 2012
Complications after the treatment of endometrial cancer: a prospective study using the French-Italian glossary
E Piovano, L Fuso, CB Poma, A Ferrero, S Perotto, E Tripodi, E Volpi, ...
International Journal of Gynecologic Cancer 24 (3), 2014
A search for predictive factors for hypersensitivity reactions to paclitaxel and platinum salts in chemotherapy for gynecologic pelvic neoplasms
E Piovano, E Pivetta, P Modaffari, F Martra, C Baima Poma, S Perotto, ...
Gynecologic and obstetric investigation 74 (1), 21-27, 2012
The role of surgery in recurrent endometrial cancer
V Zanfagnin, A Ferrero, N Biglia, G Aletti, SE Gill, PB Makdisi, F Multinu, ...
Expert review of anticancer therapy 16 (7), 741-750, 2016
Лечение раннего рака шейки матки: выживаемость, осложнения и экономические аспекты
P Zola, E Tripodi, V Zanfagnin, S Perotto, P Modaffari, F Martra, L Fuso
Сибирский онкологический журнал, 14-21, 2012
Predictors of extensive lymphatic dissemination and recurrences in node-positive endometrial cancer
V Zanfagnin, Y Huang, ME Mc Gree, AL Weaver, J Casarin, F Multinu, ...
Gynecologic Oncology 154 (3), 480-486, 2019
Results of a phase 2 trial of ribociclib and letrozole in patients with either relapsed estrogen receptor (ER)-positive ovarian cancers or relapsed ER-positive endometrial cancers.
G Colon-Otero, SJ Weroha, V Zanfagnin, NR Foster, E Asmus, ...
Journal of Clinical Oncology 37 (15_suppl), 5510-5510, 2019
Repurposing ceritinib induces DNA damage and enhances PARP inhibitor responses in high-grade serous ovarian carcinoma
A Kanakkanthara, X Hou, TL Ekstrom, V Zanfagnin, AM Huehls, RL Kelly, ...
Cancer research 82 (2), 307-319, 2022
KLF10 mediated epigenetic dysregulation of epithelial CD40/CD154 promotes endometriosis
AA Delaney, Z Khan, Y Zheng, LF Correa, V Zanfagnin, CC Shenoy, ...
Biology of Reproduction 95 (3), 62, 1-11, 2016
Sentinel lymph nodes and precision surgery in gynecologic cancer
K Ghoniem, SA Shazly, G Dinoi, V Zanfagnin, GE Glaser, A Mariani
Clinical obstetrics and gynecology 63 (1), 12-23, 2020
Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A
D Torres, X Hou, L Bale, EP Heinzen, MJ Maurer, V Zanfagnin, AL Oberg, ...
PloS one 14 (11), e0224564, 2019
The system can't perform the operation now. Try again later.
Articles 1–20